27 Jul 2021 --- Baby nutrition company ByHeart has secured US$90 million in series B funding, which will accelerate the road to market for its infant formula. D1 Capital led the funding round to support ByHeart’s impending formula launch and further the company’s innovation pipeline of mother and baby products. It builds on a series A funding round which landed the company US$70 million in April 2020.
